Skip to main content
logo
HansBiomed Corporation (KOSDAQ:042520)
South Korea flag South Korea · Delayed Price · Currency is KRW
19,500
+440 (2.31%)
At close: Aug 20, 2026

HansBiomed Cash Flow Statement

Millions KRW. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
-19,665-31,341-7,223-23,0456,147-18,289
Depreciation & Amortization
4,5715,1125,3865,1984,9024,785
Loss (Gain) From Sale of Assets
-3.42-12.4273.0216.98-1.6-54.82
Asset Writedown & Restructuring Costs
---4.4366.16--
Loss (Gain) From Sale of Investments
812.88812.881,658---
Loss (Gain) on Equity Investments
2,080557.182,2351,8572,644-
Stock-Based Compensation
-21.0942.572,44759.76226.06
Provision & Write-off of Bad Debts
-140.9953.371,568-116.39153.962,780
Other Operating Activities
20,12425,2862,14514,779-11,797-5,228
Change in Accounts Receivable
-554.82-7,281-2,215-3,621-748.02694.62
Change in Inventory
-424.97-462.78-2,558-2,645-5,9633,482
Change in Accounts Payable
-7,9241,712814.941,062-1,638-1,554
Change in Income Taxes
----124.27--
Change in Other Net Operating Assets
-14,5155,861-163.1691.851,971-1,487
Operating Cash Flow
-15,640318.341,759-3,733-4,270-14,645
Operating Cash Flow Growth
--81.90%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Capital Expenditures
-2,782-1,862-2,594-1,937-3,986-4,891
Sale of Property, Plant & Equipment
-6.97105.5161.2772.3980.8148.7
Cash Acquisitions
268.58-----
Sale (Purchase) of Intangibles
-74.64-57.18-234.71-135.76-147.84-87.04
Investment in Securities
-5,510-1,520-3,7915,1137,188-16,323
Other Investing Activities
31.55107.82-22.810.65-28.8619.78
Investing Cash Flow
-8,294-5,237-6,5953,3203,167-21,190

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Long-Term Debt Issued
-7,0007,000-15,00037,976
Total Debt Issued
-6007,0007,000-15,00037,976
Long-Term Debt Repaid
--1,190-1,130-1,093-9,925-16,919
Net Debt Issued (Repaid)
-2,5725,8105,870-1,0935,07521,057
Issuance of Common Stock
36,151----7,497
Repurchase of Common Stock
---5-788.29-4,553-20
Other Financing Activities
-268.58-0-01,053864.281,204
Financing Cash Flow
33,3105,8105,865-828.511,38729,738

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Foreign Exchange Rate Adjustments
31.58-1.3299-151.03189.65134.72
Miscellaneous Cash Flow Adjustments
------827.63
Net Cash Flow
9,408889.571,128-1,392473.14-6,790

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Free Cash Flow
-18,421-1,544-835.74-5,670-8,256-19,535
Free Cash Flow Growth
------
Free Cash Flow Margin
-14.76%-1.72%-1.03%-7.27%-11.09%-33.06%
Free Cash Flow Per Share
-1341.52-118.88-64.54-529.02-628.48-1951.22
Levered Free Cash Flow
-16,9379,427-7,4211,977-16,356-3,746
Unlevered Free Cash Flow
-15,84110,571-6,3115,429-12,429-1,560

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash Interest Paid
1,8241,8141,6321,381794.56611.45
Cash Income Tax Paid
934.94804.46327.7214.65243.111,505
Change in Working Capital
-23,419-170.85-4,121-5,237-6,3781,135